Aditxt (Nasdaq: Adtx)

Aditxt (Nasdaq: Adtx) company information, Employees & Contact Information

Aditxt is a social innovation platform. Every year, billions of individuals face health challenges such as autoimmune diseases, misdiagnosis, infectious diseases, organ failure, reproductive health issues, malnutrition, cancer, as well as barriers to accessing healthcare. Innovations with immense potential to address critical healthcare challenges are all around us. Untapped innovations hold the key to transformative solutions. Socially owned and capitalized as  a Nasdaq listed company with a mission of discovering, developing and deploying promising health innovations. Now is the time to inspire and mobilize the social capital inherent in a global community of stakeholders to actively participate in the discovery, development, and implementation of health solutions that could benefit humanity.

Company Details

Employees
22
Founded
-
Address
Richmond, Va 23219, Us
Email
so****@****txt.com
Industry
Health And Human Services
NAICS
Administration of Human Resource Programs
Administration of Veterans' Affairs
Website
aditxt.com
HQ
Richmond, VA
Looking for a particular Aditxt (Nasdaq: Adtx) employee's phone or email?

Aditxt (Nasdaq: Adtx) Questions

News

Pearsanta (NASDAQ: ADTX) begins study of endometriosis blood test, up to 1,000 participants - Stock Titan

Pearsanta (NASDAQ: ADTX) begins study of endometriosis blood test, up to 1,000 participants Stock Titan

Aditxt’s Subsidiary, Pearsanta, Inc. Engages Spartan Capital as Lead Underwriter for its Planned IPO Intending to Drive Clinical Validation and Commercial Rollout of Its Mitomic™ Platform Technology for Early Detection of Cancers and Other Diseases - Yahoo Finance

Aditxt’s Subsidiary, Pearsanta, Inc. Engages Spartan Capital as Lead Underwriter for its Planned IPO Intending to Drive Clinical Validation and Commercial Rollout of Its Mitomic™ Platform Technology for Early Detection of Cancers and Other Diseases Yahoo Finance

Aditxt and Crypto.com Sign Agreement for Custodial Crypto Account, Announce ADTX Share Access on Crypto.com as Part of the Larger bitXbio™ Initiative - Crypto.com

Aditxt and Crypto.com Sign Agreement for Custodial Crypto Account, Announce ADTX Share Access on Crypto.com as Part of the Larger bitXbio™ Initiative Crypto.com

96 Patents Secured: Aditxt's DNA Platform Could Revolutionize $160B Autoimmune Treatment Market - Stock Titan

96 Patents Secured: Aditxt's DNA Platform Could Revolutionize $160B Autoimmune Treatment Market Stock Titan

Evofem Anticipates Approval of Merger with Aditxt at Upcoming Stockholder Meeting - PR Newswire

Evofem Anticipates Approval of Merger with Aditxt at Upcoming Stockholder Meeting PR Newswire

Aditxt, Inc. (NASDAQ: ADTX) Provides Shareholder Update and Planned Strategy for Achieving Commercial Scale - Business Wire

Aditxt, Inc. (NASDAQ: ADTX) Provides Shareholder Update and Planned Strategy for Achieving Commercial Scale Business Wire

Evofem Acquired by Aditxt for $100M - San Diego Business Journal

Evofem Acquired by Aditxt for $100M San Diego Business Journal

Aditxt signs custody agreement with Crypto.com for digital asset treasury - Investing.com

Aditxt signs custody agreement with Crypto.com for digital asset treasury Investing.com

Why Aditxt Inc. (ADTX) Went Down On Thursday? - Yahoo Finance

Why Aditxt Inc. (ADTX) Went Down On Thursday? Yahoo Finance

Aditxt Unveils Revolutionary Bitcoin-Backed Treasury Strategy to Fund Biotech Pipeline and 2026 IPO Plans - Stock Titan

Aditxt Unveils Revolutionary Bitcoin-Backed Treasury Strategy to Fund Biotech Pipeline and 2026 IPO Plans Stock Titan

Aditxt Issues Shareholder Update - Business Wire

Aditxt Issues Shareholder Update Business Wire

Aditxt Strengthens Board with Women's Health Pioneer: Evofem CEO Brings 30-Year Industry Expertise - Stock Titan

Aditxt Strengthens Board with Women's Health Pioneer: Evofem CEO Brings 30-Year Industry Expertise Stock Titan

Appili Therapeutics Provides Update on Arrangement with Aditxt, Inc. - Yahoo Finance

Appili Therapeutics Provides Update on Arrangement with Aditxt, Inc. Yahoo Finance

Aditxt Reveals Ambitious Roadmap: Multiple Clinical Trials and 2025 Product Launch - Stock Titan

Aditxt Reveals Ambitious Roadmap: Multiple Clinical Trials and 2025 Product Launch Stock Titan

Major 1:250 Reverse Split Coming for Aditxt Stock: Key Details for Shareholders - Stock Titan

Major 1:250 Reverse Split Coming for Aditxt Stock: Key Details for Shareholders Stock Titan

Aditxt's Cancer Detection Unit Pearsanta Plans 2025 IPO, Advancing Mitomic Technology Platform - Stock Titan

Aditxt's Cancer Detection Unit Pearsanta Plans 2025 IPO, Advancing Mitomic Technology Platform Stock Titan

Aditxt Secures Overwhelming Shareholder Approval for Appili Therapeutics Acquisition - Stock Titan

Aditxt Secures Overwhelming Shareholder Approval for Appili Therapeutics Acquisition Stock Titan

Aditxt Completes Third Parent Equity Investment Under Amended and Restated Merger Agreement With Evofem - Stock Titan

Aditxt Completes Third Parent Equity Investment Under Amended and Restated Merger Agreement With Evofem Stock Titan

Aditxt Appoints Corinne Pankovcin as President and Thomas Farley as CFO - citybiz

Aditxt Appoints Corinne Pankovcin as President and Thomas Farley as CFO citybiz

Aditx Therapeutics, Inc. (Aditxt) Announces Pricing of Initial Public Offering - GlobeNewswire

Aditx Therapeutics, Inc. (Aditxt) Announces Pricing of Initial Public Offering GlobeNewswire

Troubled Evofem, marketer of contraceptive gel Phexxi, sells itself to Aditxt in $100M deal - Fierce Pharma

Troubled Evofem, marketer of contraceptive gel Phexxi, sells itself to Aditxt in $100M deal Fierce Pharma

Aditxt, Inc.’s Wholly-Owned Subsidiary Pearsanta, Inc. Looks to Expand Customer Base, Payor Access, and Genetic Testing with a Non-Binding Letter of Intent to Acquire Natural State Laboratories and Natural State Genomics - Business Wire

Aditxt, Inc.’s Wholly-Owned Subsidiary Pearsanta, Inc. Looks to Expand Customer Base, Payor Access, and Genetic Testing with a Non-Binding Letter of Intent to Acquire Natural State Laboratories and Natural State Genomics Business Wire

CORRECTION: Aditx Therapeutics, Inc. (Aditxt) Announces Closing of Initial Public Offering - GlobeNewswire

CORRECTION: Aditx Therapeutics, Inc. (Aditxt) Announces Closing of Initial Public Offering GlobeNewswire

Why Aditxt (ADTX) Stock Is Skyrocketing - Benzinga

Why Aditxt (ADTX) Stock Is Skyrocketing Benzinga

Aditxt and Evofem Seek Approval for Merger, Closing Expected Q4 2024 - Stocktwits

Aditxt and Evofem Seek Approval for Merger, Closing Expected Q4 2024 Stocktwits

How Aditxt and Crypto.com are Bridging Biotech and Crypto Finance - Hackernoon

How Aditxt and Crypto.com are Bridging Biotech and Crypto Finance Hackernoon

Physician and Media Personality Dr. Drew Pinsky, Dr. Drew, - GlobeNewswire

Physician and Media Personality Dr. Drew Pinsky, Dr. Drew, GlobeNewswire

ADTX Stock Price and Chart — NASDAQ:ADTX - TradingView

ADTX Stock Price and Chart — NASDAQ:ADTX TradingView

Aditxt Announces Closing of $20.0 Million Public Offering | News | postregister.com - FinancialContent

Aditxt Announces Closing of $20.0 Million Public Offering | News | postregister.com FinancialContent

News - FinancialContent

News FinancialContent

BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Closes on Recently Announced $20M Public Offering - FinancialContent

BioMedNewsBreaks – Aditxt Inc. (NASDAQ: ADTX) Closes on Recently Announced $20M Public Offering FinancialContent

Top Aditxt (Nasdaq: Adtx) Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant